Home › Targets › prostacyclin receptor
prostacyclin receptor (2 companies · 12 programs)
Companies with an active program directed at prostacyclin receptor.
- YUTREPIA — Pulmonary Arterial Hypertension Approved
- YUTREPIA — Pulmonary Hypertension Associated with Interstitial Lung Disease Approved
- YUTREPIA — Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease Phase 1
- YUTREPIA — Idiopathic Pulmonary Fibrosis Phase 1
- YUTREPIA — Progressive Pulmonary Fibrosis Phase 1
- YUTREPIA — Raynaud's Phenomenon Associated with Systemic Sclerosis Phase 1
- L606 — Pulmonary Arterial Hypertension Phase 3
- L606 — Pulmonary Hypertension Associated with Interstitial Lung Disease Phase 3
- TPIP — Pulmonary Hypertension associated with Interstitial Lung Disease Phase 3
- TPIP — Pulmonary Arterial Hypertension Phase 3
- TPIP — Progressive Pulmonary Fibrosis
- TPIP — Idiopathic Pulmonary Fibrosis
